Medical research takes years and significant funding to achieve outcomes. To help fast-track research discoveries through development, clinical trials and translation to market, TRI-based researchers collaborate and share resources and knowledge. As a result, this shared expertise sees patterns develop in their work according to areas of specialisation. These patterns change over time as new priorities and technologies emerge.
TRI-based researchers from QUT are refining portable imaging technology to create 3D images of breast tissue, with the aim of improving cancer diagnosis and treatment.
Critical insights into prostate cancer have been uncovered, with researchers using them to identify therapeutic targets and developing a diagnostic tool.
Scientists have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows cell growth.
Professor H. Peter Soyer has been awarded $10 million for the Australian Centre of Excellence in Melanoma Imaging and Diagnosis at TRI.
Researchers are using theranostics to detect and treat some of the deadliest cancers, including pancreatic, ovarian, and bladder cancer.
Researchers from The University of Queensland and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.
TRI-based researchers from The University of Queensland have unlocked a way of fighting Listeria infections, which can cause severe illness in pregnant women and people with compromised immune systems.
TRI-based researcher Dr Joshua Tobin, a member of Mater Research’s Blood Cancer Group led by Professor Maher Gandhi, has recently been awarded $150,000 in funding to further his research into lymphoma.
Immunologist Dr Jazmina Gonzalez Cruz is leading a pioneering research program to identify and design personalised cancer treatments.
Professor Kum Kum Khanna has joined Mater Research, with the aim of developing new treatments, or repurposing FDA-approved medicines, for treatment of aggressive forms of breast and ovarian cancer.
A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain’s ability to grow new cells, QUT researchers based at TRI have found.
Researchers based at TRI are developing Parkinson’s disease treatments by targeting the gut microbiome.
Children who consume too much sugar could be at greater risk of becoming obese, hyperactive and cognitively impaired as adults, a study has found.
TRI-based scientists from Mater Research are developing research models that more accurately replicate the human immune system.
Research in the Journal of Clinical Oncology has reported findings that may inform treatment and improve outcomes for patients with follicular lymphoma.
TRI-based Mater Researchers have discovered that an immune factor released by white blood cells during infection or inflammation works to suppress the body’s immune response instead of enhancing it.
Researchers have unlocked a way of fighting listeria infections, which can cause severe illness in pregnancy and people with compromised immune systems.
QUT scientists at the Translational Research Institute (TRI) are harnessing a new class of pharmaceutical compounds, known as aptamers, to develop a drug to boost the immune system’s ability to fight cancer.
TRI-based Mater Researchers have discovered that an immune factor released by white blood cells during infection or inflammation works to suppress the body’s immune response instead of enhancing it.
TRI-based researchers from The University of Queensland, Mater Research and Queensland University of Technology are sharing in more than $12million in the latest round of National Health and Medical Research Council (NHMRC) funding.
Queensland researchers have become the first in Australia to use human stem cells to generate fully functioning skin tissue in a laboratory, a significant step towards better treatments for severe burns and wounds.
Professor Jo Forbes from Mater Research says Type 1 diabetes in children is twice as common now than it was 20 years ago.
A new spin-out from The University of Queensland will develop a novel therapy for the growing problem of obesity-related liver disease.
TRI-based scientists from Mater Research and The University of Queensland have recently identified a potential treatment to enhance the healing of fractures among osteoporosis sufferers.
Patient recruitment is underway for a University of Queensland-led clinical trial to test the effectiveness of a diabetes drug to slow the progression of polycystic kidney disease.
A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain’s ability to grow new cells, QUT researchers based at TRI have found.
The possibility of a mouthwash or nasal spray to prevent or reduce the spread of the COVID-19 infections is being investigated by TRI-based QUT scientists.
DNA changes consistent with life-threatening pregnancy complications have been found in the placentas of pregnant women infected by COVID-19, according to researchers from The University of Queensland.
A new study has identified that fat molecules contribute to sleep disturbances in children diagnosed with autism, with results now published in Nature Medicine.
A microorganism that helps reduce the release of the greenhouse gas methane into the atmosphere has been found to be a ‘shape shifter’.
Liver damage could be a major outcome of severe COVID-19 infection in a landmark study involving TRI-based researchers.
A new approach to rheumatoid arthritis is being developed, with Phase I clinical trials showing promising results.
Researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.